CJC NO DAC 5MG IPA 5MG

Description

What is CJC NO DAC / IPA?

This listing names CJC without DAC and IPA. CJC without DAC commonly denotes modified GRF (1–29), a GHRH analogue; IPA commonly denotes ipamorelin, a synthetic ghrelin-receptor agonist peptide. Confirm both component identities and the blend specification with the supplier before experimental use.

Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.

Published study findings and evidence limits

Evidence limits for this blend

Studies of individual compounds do not establish the effectiveness of this CJC without DAC / IPA blend. A placebo-controlled ipamorelin trial after bowel surgery found no significant improvement in its key or secondary efficacy analyses. Exact component identities and the blend formulation require confirmation; no proven health benefit is claimed.

Sources: Ipamorelin postoperative-ileus trial (2014).

Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.

For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.